Xiaomei Zhang

Tianjin, 300192, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Efficacy analysis of CAR-T cells against CD123-positive malignant tumors and exploration of the feasibility of combination therapy with venetoclax.

Efficacy analysis of CAR-T cells against CD123-positive malignant tumors and exploration of the feasibility of combination therapy with venetoclax.

Journal: Annals of hematology

Published: March 30, 2026

TA-TMA occurring after sequential CD7 CAR-T cell therapy and allogeneic hematopoietic stem cell transplantation: a case report.

TA-TMA occurring after sequential CD7 CAR-T cell therapy and allogeneic hematopoietic stem cell transplantation: a case report.

Journal: Frontiers in immunology

Published: March 16, 2026

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Journal: Journal of hematology & oncology

Published: September 02, 2025

A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma.

A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma.

Journal: Clinical and experimental medicine

Published: June 12, 2025

Correction: Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemia.

Correction: Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemia.

Journal: Cancer immunology, immunotherapy : CII

Published: June 04, 2025

A novel malnutrition assessment model predicts the inflammatory storm of relapsed/refractory acute myeloid leukemia following C-type lectin-like molecule-1 chimeric antigen receptor T therapy.

A novel malnutrition assessment model predicts the inflammatory storm of relapsed/refractory acute myeloid leukemia following C-type lectin-like molecule-1 chimeric antigen receptor T therapy.

Journal: Frontiers in nutrition

Published: May 13, 2025

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis.

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis.

Journal: Frontiers in oncology

Published: December 22, 2024

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Journal: Frontiers in immunology

Published: November 19, 2024

Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report.

Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report.

Journal: Blood advances

Published: October 03, 2024

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Journal: Frontiers in immunology

Published: September 04, 2024

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis.

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis.

Journal: Frontiers in oncology

Published: August 11, 2024

Targeting CD19 CAR-T With MND Promoter Enhances Tumour Killing.

Targeting CD19 CAR-T With MND Promoter Enhances Tumour Killing.

Journal: Journal of cellular and molecular medicine

Published: July 17, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026